Page 22 - Central Drug Authority Annual Report 2021
P. 22
CHAPTER 2 - GOVERNANCE
7KLV FKDSWHU RXWOLQHV WKH VWUXFWXUH DQG IXQFWLRQV RI WKH &'$ H (QVXUH WKDW HDFK GHSDUWPHQW RI VWDWH KDV LWV SHUIRU-
DV RXWOLQHG LQ WKH 3UHYHQWLRQ RI DQG 7UHDWPHQW IRU PDQFH LQGLFDWRUV
6XEVWDQFH $EXVH $FW $FW RI DQG WKH 1'03 I )DFLOLWDWH WKH LQLWLDWLRQ DQG SURPRWLRQ RI PHDVXUHV WR
2019 -2020. DGGUHVV WKH XVH RI VXEVWDQFHV
J (QVXUH WKH HVWDEOLVKPHQW DQG PDLQWHQDQFH RI LQIRUPD-
1. FUNCTONS AND ROLE OF THE CDA WLRQ V\VWHPV ZKLFK ZLOO VXSSRUW WKH LPSOHPHQWDWLRQ
HYDOXDWLRQ DQG RQJRLQJ GHYHORSPHQW RI WKH 1'03
,Q WHUPV RI WKH 3UHYHQWLRQ RI DQG 7UHDWPHQW IRU 6XEVWDQFH K 6XEPLW DQ $QQXDO 5HSRUW WKDW VHWV RXW D FRPSUHKHQVLYH
$EXVH $FW $FW RI WKH &'$ PXVW VXEPLW DQ GHVFULSWLRQ RI WKH QDWLRQDO HIIRUW UHODWLQJ WR DGGUHVVLQJ
$QQXDO 5HSRUW RQ LWV DFKLHYHPHQWV DJDLQVW WKH JRDOV RI WKH VXEVWDQFH DEXVH
1'03 7KH &'$ IRU WKH SHULRG XQGHU UHYLHZ KDV UHWLUHG ,W L (QVXUH WKH GHYHORSPHQW RI HIIHFWLYH VWUDWHJLHV RQ
VWDQGV WR UHDVRQ WKHUHIRUH WKDW WKH QHZ &'$ ZLOO FRPSOHWH SUHYHQWLRQ HDUO\ LQWHUYHQWLRQ UHLQWHJUDWLRQ DQG
WKH WDVN RI GUDIWLQJ WKH &'$ $QQXDO 5HSRUW LQ WHUPV DIWHUFDUH VHUYLFHV DQG LQ SDUWLFXODU WKH GHYHORSPHQW RI
RI WKH 1'03 7KLV SODQ PXVW EH SUHVHQWHG WR HIIHFWLYH VWUDWHJLHV UHJDUGLQJ WKH SUHYHQWLRQ RI +,9
3DUOLDPHQW E\ WKH 0LQLVWHU RI 6RFLDO 'HYHORSPHQW DQQXDOO\ LQIHFWLRQ DQG RWKHU PHGLFDO FRQVHTXHQFHV UHODWHG WR
E\ WKH 6HSWHPEHU VXEVWDQFH DEXVH
M $GYLVH WKH JRYHUQPHQW RQ SROLFLHV DQG SURJUDPPHV LQ
7KH 3UHYHQWLRQ RI DQG 7UHDWPHQW IRU 6XEVWDQFH $EXVH $FW WKH ˉHOG RI VXEVWDQFH DEXVH DQG GUXJ WUDIˉFNLQJ
$FW 1R RI DQG WKH 1DWLRQDO 'UXJ 0DVWHU 3ODQ N 5HFRPPHQG WR &DELQHW WKH UHYLHZ RI WKH 1'03 HYHU\
ȝ DOVR VSHFLˉHV WKH SRZHUV DQG GXWLHV RI WKH &'$ ˉYH \HDUV
DV IROORZV O 2UJDQLVH D ELHQQLDO VXPPLW RQ VXEVWDQFH DEXVH WR
D 2YHUVHH DQG PRQLWRU WKH LPSOHPHQWDWLRQ RI WKH 1'03 HQDEOH UROH SOD\HUV LQ WKH ˉHOG RI VXEVWDQFH DEXVH WR
E )DFLOLWDWH DQG HQFRXUDJH WKH FRRUGLQDWLRQ RI VWUDWHJLF VKDUH LQIRUPDWLRQ
SURMHFWV P ([HUFLVH VXFK SRZHUV DQG SHUIRUP VXFK GXWLHV DV PD\
F )DFLOLWDWH WKH UDWLRQDOLVDWLRQ RI H[LVWLQJ UHVRXUFHV DQG EH GHWHUPLQHG E\ WKH 0LQLVWHU IURP WLPH WR WLPH
PRQLWRU WKHLU HIIHFWLYH XVH
G (QFRXUDJH JRYHUQPHQW GHSDUWPHQWV DQG SULYDWH LQVWLWX-
WLRQV WR FRPSLOH SODQV WR DGGUHVV VXEVWDQFH DEXVH LQ
line with the goals of the NDMP
20 Annual Report 2020/2021 Central Drug Authority
